General MedicationsTOPICALGeneric
SULFAMYLON
MAFENIDE ACETATE
Standard Dose
5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SULFAMYLON is listed in Drugs@FDA under application 019832 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MAFENIDE ACETATE Form and strength FOR SOLUTION;TOPICAL - 5% Sponsor MYLAN INSTITUTIONAL Submission history Latest submission status date: 2015-01-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview SULFAMYLON is listed in Drugs@FDA under application 019832 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MAFENIDE ACETATE Form and strength FOR SOLUTION;TOPICAL - 5% Sponsor MYLAN INSTITUTIONAL Submission history Latest submission status date: 2015-01-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.